Columbia Sportswear Co
Change company Symbol lookup
Select an option...
COLM Columbia Sportswear Co
HEAR Turtle Beach Corp
GWPH GW Pharmaceuticals PLC
GTBIF Green Thumb Industries Inc
GOOG Alphabet Inc
GILD Gilead Sciences Inc
GBLX GB Sciences Inc
FANG Diamondback Energy Inc
EOG EOG Resources Inc
DVN Devon Energy Corp
Go

Consumer Discretionary : Textiles, Apparel & Luxury Goods | Mid Cap Blend
Company profile

Columbia Sportswear Company is an apparel and footwear company. The Company designs, sources, markets and distributes outdoor lifestyle apparel, footwear, accessories and equipment under the Columbia, Mountain Hardwear, Sorel, prAna and other brands. Its geographic segments are the United States, Latin America and Asia Pacific (LAAP), Europe, Middle East and Africa (EMEA), and Canada. The Company develops and manages its merchandise in categories, including apparel, accessories and equipment, and footwear. It distributes its products through a mix of wholesale distribution channels, its own direct-to-consumer channels (retail stores and e-commerce), independent distributors and licensees. As of December 31, 2016, its products were sold in approximately 90 countries. In 59 of those countries, it sells to independent distributors to whom it has granted distribution rights. Contract manufacturers located outside the United States manufacture all of its products.

Closing Price
$66.18
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
472,664
0

T2 Biosystems to Report Fourth Quarter and Full Year 2019 Financial Results on February 24, 2020

4:05 pm ET February 12, 2020 (Globe Newswire) Print

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the fourth quarter and full year 2019 after market close on Monday, February 24, 2020. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by dialing 1-877-407-9208 (U.S.) or 1-201-493-6784 (International). A live and archived webcast of the event will be available at www.t2biosystems.com on the Investors page in the Events & Presentations section.

About T2 Biosystems:

T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems' products include the T2Dx(R) Instrument, the T2Candida(R) Panel, the T2Bacteria(R) Panel, and the T2Resistance(TM) Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR(R)) technology. T2 Biosystems has an active pipeline of future products, including products for the detection of additional species and antibiotic resistance markers of sepsis pathogens, and tests for Lyme disease.

Media Contact:

Gina Kent, Vault Communications

gkent@vaultcommunications.com

610-455-2763

Investor Contact:

Philip Trip Taylor, Gilmartin Group

philip@gilmartinIR.com

415-937-5406

https://ml.globenewswire.com/media/21ce43b1-81a5-42af-8c47-c2df2e179d21/small/t2biosystems-logo-jpg.jpg

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.